Development and validation of an LC-MS/MS method for the simultaneous estimation of tadalafil and macitentan in rat plasma: Greenness assessment and design of experiment approach

被引:3
作者
Gandu, Sravanthi [1 ]
Gandla, Kumaraswamy [1 ]
Repudi, Lalitha [1 ]
机构
[1] Chaitanya Deemed be Univ, Dept Pharm, Gandipet Himayath Nagar Vill, Hyderabad 500075, Telangana, India
来源
GREEN ANALYTICAL CHEMISTRY | 2025年 / 12卷
关键词
Tadalafil; Macitentan; LC-MS/MS; Rat plasma; Design of expert; Green analytical chemistry; SIMULTANEOUS QUANTIFICATION; PULMONARY; MANAGEMENT; INHIBITORS;
D O I
10.1016/j.greeac.2025.100211
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This study presents the development and validation of a sensitive LC-MS/MS method for the simultaneous quantification of tadalafil and macitentan in rat plasma, enabling detailed pharmacokinetic profiling following single-dose administration. Optimization of critical parameters, including organic phase composition (50% acetonitrile), flow rate (1.0 mL/min), and pH (3.2), was achieved using a Box-Behnken Design, ensuring accurate separation and quantification. The retention times were 4.13 min for tadalafil, 5.32 min for macitentan, and 7.89 min for the internal standard, ritonavir. The method adhered to regulatory validation guidelines, linearity was observed over a concentration range of 20 to 400 ng/mL for tadalafil and 5 to 100 ng/ml for macitentan, yielding correlation coefficients of 0.9997 and 0.9998, respectively, with limits of quantitation (LOQs) of 19.10 ng/mL for tadalafil and 4.21 ng/mL for macitentan. Precision, expressed as %CV, was consistently below 15% for both intra- and inter-day variability. Drug recovery exceeded 98%, and stability tests demonstrated robustness under various conditions, with %CV values remaining under 15%. Pharmacokinetic studies in male Wistar rats (tadalafil: 0.0033 mg/kg; macitentan: 0.0003 mg/kg) revealed distinct absorption and elimination profiles. Tadalafil exhibited a peak concentration (Cmax) of 164.2 ng/mL at 1.5 h, an AUC0-t of 806 ng & sdot;h/mL, and a halflife of 5 h, indicative of rapid clearance. In contrast, macitentan displayed a lower Cmax of 43.8 ng/mL at 2 h, an AUC0-t of 987 ng & sdot;h/mL, and a prolonged half-life of 15 h, suggesting sustained systemic exposure. These pharmacokinetic variations highlight the potential for tailored dosing strategies. Environmental assessment using green analytical chemistry tools confirmed the eco-friendly design of the method, characterized by reduced solvent consumption and low toxicity. This validated LC-MS/MS method provides a robust and sustainable analytical solution for preclinical pharmacokinetic studies, delivering reliable data to inform safe and effective dosing of tadalafil and macitentan.
引用
收藏
页数:13
相关论文
共 37 条
[1]   Fabric phase sorptive extraction coupled with UPLC-ESI-MS/MS method for fast and sensitive quantitation of tadalafil in a bioequivalence study [J].
Ahmed, Sameh A. ;
Alalawi, Ali M. ;
Shehata, Ahmed M. ;
Alqurshi, Abdulmalik A. ;
Alahmadi, Yaser M. ;
Ali, Hany S. M. .
SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (08) :1143-1152
[2]   Sustainable HPLC technique for measurement of antidiabetic drugs: Appraisal of green and white metrics, content uniformity, and in vitro dissolution [J].
Al-Wasidi, Asma S. ;
Ahmed, Hoda A. ;
Mahgoub, Samar M. ;
Mohamed, Mahmoud A. ;
Nassar, Hossam F. .
REVIEWS IN ANALYTICAL CHEMISTRY, 2024, 43 (01)
[3]  
Alimovna R.D., 2023, Modern Methods of Diagnosing Complications in the Pulmonary Artery on comorbid State of Respiratory Diseases, P1
[4]   Dual drug-loaded cubosome nanoparticles for hepatocellular carcinoma: a design of experiment approach for optimization and in vitro evaluation [J].
Badiger, Poorvika ;
Mannur, V. S. ;
Koli, Rahul .
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 10 (01)
[5]   Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans [J].
Bruderer, Shirin ;
Hopfgartner, Gerard ;
Seiberling, Michael ;
Wank, Janine ;
Sidharta, Patricia N. ;
Treiber, Alexander ;
Dingemanse, Jasper .
XENOBIOTICA, 2012, 42 (09) :901-910
[6]  
Burger CD, 2017, CLINICOECONOMIC OUTC, V9, P731, DOI 10.2147/CEOR.S119117
[7]   Advances in the management of pulmonary arterial hypertension [J].
Deshwal, Himanshu ;
Weinstein, Tatiana ;
Sulica, Roxana .
JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (07) :1270-1280
[8]   Bioanalytical method validation considerations for LC-MS/MS assays of therapeutic proteins [J].
Duggan, Jeffrey X. ;
Vazvaei, Faye ;
Jenkins, Rand .
BIOANALYSIS, 2015, 7 (11) :1389-1395
[9]   Simultaneous quantification of endothelin receptor antagonists and phosphodiesterase 5 inhibitors currently used in pulmonary arterial hypertension [J].
Enderle, Yeliz ;
Witt, Lukas ;
Wilkens, Heinrike ;
Gruenig, Ekkehard ;
Haefeli, Walter E. ;
Burhenne, Juergen .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2017, 143 :291-298
[10]   Dried Blood Spot Technique for the Monitoring of Ambrisentan, Bosentan, Sildenafil, and Tadalafil in Patients with Pulmonary Arterial Hypertension [J].
Enderle, Yeliz ;
Meid, Andreas D. ;
Friedrich, Joerg ;
Gruenig, Ekkehard ;
Wilkens, Heinrike ;
Haefeli, Walter E. ;
Burhenne, Juegen .
ANALYTICAL CHEMISTRY, 2015, 87 (24) :12112-12120